Filippo Riva
Amministratore Delegato presso Humabs BioMed SA
Provenienza dei contatti di primo grado di Filippo Riva
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Humabs BioMed SA
Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Filippo Riva tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
The Caisse de dépôt et placement du Québec
The Caisse de dépôt et placement du Québec Investment ManagersFinance The Caisse de dépôt et placement du Québec (CDPQ) is a government-owned institutional fund manager headquartered in Montréal, Canada. Founded in 1965, CDPQ manages the funds of several depositor groups primarily for public and parapublic pension and insurance plans which pay out benefits to more than two million Quebecers each year. | Investment Managers | Director/Board Member | |
IBEX TECHNOLOGIES | Medical Specialties | Director/Board Member | |
Università della Svizzera Italiana | College/University | Corporate Officer/Principal | |
AFFIMED N.V. | Biotechnology | Chairman | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
University of Freiburg | College/University | Doctorate Degree | |
McGill University | College/University | Graduate Degree | |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Chairman | |
University of Pavia | College/University | Undergraduate Degree | |
Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal | |
University of Genoa | College/University | Corporate Officer/Principal | |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
European Molecular Biology Organization | Corporate Officer/Principal | ||
Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
Sir George Williams University | College/University | Undergraduate Degree | |
SuppreMol GmbH
SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chairman | |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Cell Medica Switzerland AG
Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Founder | |
Amgen (Europe) GmbH | Sales & Marketing | ||
Haemosan, Inc.
Haemosan, Inc. Regional BanksFinance Haemosan, Inc. operates as a bank holding company. The company was founded on August 20, 1979 and is headquartered in Mount-Royal, Canada. | Regional Banks | President | |
Swiss Academy of Medical Sciences | Corporate Officer/Principal | ||
Lipideon Biotechnology AG
Lipideon Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Lipideon Biotechnology AG engages in the provision of pharmaceutical activities. The company was founded on February 26, 2002 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Chairman | |
HHC consulting | Founder | ||
Affimed AG | Chairman | ||
Adienne SA
Adienne SA Pharmaceuticals: OtherHealth Technology Adienne SA is a biopharmaceutical company engages in the provision of medical development. It focuses on orphan drugs for the treatment of various haematological and immunological diseases. The company was founded on Lugano, Switzerland. | Pharmaceuticals: Other | Director/Board Member | |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Biotechnology | Chairman | |
Institute For Research In Biomedicine
Institute For Research In Biomedicine BiotechnologyHealth Technology The Institute for Research in Biomedicine provides research and development services in the field of biomedicine. | Biotechnology | Director/Board Member | |
VIR BIOTECHNOLOGY, INC. | Biotechnology | Corporate Officer/Principal | |
Orion Biotechnology Canada Ltd.
Orion Biotechnology Canada Ltd. BiotechnologyHealth Technology Orion Biotechnology Canada Ltd. operates as pharmaceutical company. The company was founded by Rudolf Bom in 2011 and is headquartered in Ottawa, Canada. | Biotechnology | Chairman | |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Chairman | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chairman |
Statistiche
Distribuzione geografica
Svizzera | 13 |
Canada | 8 |
Germania | 8 |
Italia | 3 |
Svezia | 2 |
Settori
Health Technology | 13 |
Consumer Services | 9 |
Commercial Services | 7 |
Finance | 4 |
Posizioni
Chairman | 14 |
Director/Board Member | 11 |
Corporate Officer/Principal | 9 |
Independent Dir/Board Member | 4 |
Founder | 3 |
Contatti più connessi
Insiders | |
---|---|
Thomas O. Hecht | 24 |
Antonio Lanzavecchia | 12 |
Ulrich M. Grau | 1 |
William J. Rutter | 1 |
- Borsa valori
- Insiders
- Filippo Riva
- Connessioni Società